Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-13-000094
Filing Date
2013-02-14
Accepted
2013-02-13 17:46:54
Documents
1
Group Members
DOMINIQUE SEMONMERLIN NEXUS III, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss164869_sc13ga.htm SC 13G/A 125384
  Complete submission text file 0000947871-13-000094.txt   127167
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Subject) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60307 | Film No.: 13604854
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

EIN.: 000000000
Type: SC 13G/A